Five-Year Update of the Phase 2 ELARA Trial of Tisagenlecleucel in Patients (pts) with relapsed/refractory Follicular Lymphoma (r/r FL)

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Stephen J. Schuster, Catherine Thiéblemont, Michael John Dickinson, Joaquin Martinez-Lopez, Arne Kolstad, Jason Butler, Monalisa Ghosh, Leslie L. Popplewell, Julio C. Chávez, Emmanuel Bachy, Koji Kato, Hideo Harigae
+23 more Marie José Kersten, Charalambos Babis Andreadis, Peter A. Riedell, Phoebe Joy Ho, José Antonio Pérez Simón, Andy Chen, Loretta J. Nastoupil, Bastian von Tresckow, Andres Jose Maria Ferreri, Takanori Teshima, Piers Patten, Joseph P. McGuirk, Fritz C. Offner, Andreas Viardot, Pier Luigi Zinzani, Aiesha Zia, Rakesh Awasthi, Roberto Javier Ramos, Meryem Ktiouet Dawson, Pei Hsu, Darragh O’Donovan, Nathan Hale Fowler, Martin H. Dreyling
DOI: 10.1016/j.jtct.2025.12.077
Cited by: 0

Fields of Study & Subjects

CAR-T cell therapy research Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S49–S50
Publication date
1 February 2026
Language
EN